Antipsychotic Prescribing at NEI Fall Congress 2026

3 sessions on antipsychotic prescribing · November 5–8, 2026, Colorado Springs, CO. Compare antipsychotic prescribing at other meetings →

Wednesday, November 4

  • Symposium · Child & Adolescent Psychiatry Academy

    Should I Stay or Should I Go? Using Dopamine Receptor Blocking Agents in Pediatrics

    Jeffrey Robert Strawn

    Weighs when to start, continue, or stop dopamine receptor blocking agents in pediatric patients, including safety and monitoring considerations.

    Child & Adolescent · Drug Interactions & Safety

Thursday, November 5

  • Symposium

    Efficacy, Acceptability, and Accessibility and Accessibility of SDA-PAs: Shared Decision Making in the Selection and Sequencing of Treatments for MDD

    Roger S. McIntyre · Thomas L. Schwartz

    Applies shared decision-making to selecting and sequencing serotonin-dopamine activity partial agonists among MDD treatment options. Title reproduced exactly as published on the agenda.

    Depression

  • Symposium

    Time Is Brain: Early Adoption of Long-Acting Injectables to Improve Functional Outcomes in Serious Mental Illness

    Christoph U. Correll

    Makes the case for earlier use of long-acting injectable antipsychotics in serious mental illness, with shared decision-making strategies.

    Long-Acting Injectables · Serious Mental Illness

Other topics at this meeting

Child & Adolescent 5Neuroscience & Mechanisms 5Depression 4ADHD 3Tardive Dyskinesia & Movement Disorders 3Sleep & Insomnia 3Anxiety Disorders 2Deprescribing & Polypharmacy 2Practice, Policy & Workforce 2Schizophrenia & Psychosis 2Serious Mental Illness 2Stimulants & ADHD Medications 2

Full program overview →